astragaloside a has been researched along with Stroke in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 4 (50.00) | 24.3611 |
2020's | 4 (50.00) | 2.80 |
Authors | Studies |
---|---|
Fan, X; Li, R; Zhang, S; Zheng, Y; Zhou, Y | 1 |
Liu, C; Tang, B; Wang, L | 1 |
Chen, L; Cui, G; He, J; Huan, Q; Lu, Z; Shi, Z; Wang, Y; Xu, Q; Zhang, C | 1 |
Duan, CQ; Liang, C; Ni, GX; Wang, J; Wang, P; Wang, YL | 1 |
Cai, SQ; Wang, D; Xu, F; Ye, J; Zhang, WW | 1 |
Kan, P; Wang, J; Xiang, L; Xu, N; Yang, P; Yao, X; Zhu, Y | 1 |
Chang, CP; Chiu, BY; Hsu, YC; Lin, JW; Lin, MT; Liu, WP; Yu, JS | 1 |
Wang, HL; Xu, MB; Zheng, GQ; Zhou, QH; Zhou, XL | 1 |
1 review(s) available for astragaloside a and Stroke
Article | Year |
---|---|
Astragaloside IV for Experimental Focal Cerebral Ischemia: Preclinical Evidence and Possible Mechanisms.
Topics: Amino Acid Sequence; Animals; Brain Ischemia; Drug Evaluation, Preclinical; Models, Molecular; Publication Bias; Saponins; Stroke; Treatment Outcome; Triterpenes | 2017 |
7 other study(ies) available for astragaloside a and Stroke
Article | Year |
---|---|
Investigation on the potential targets of Astragaloside IV against intracerebral hemorrhage based on network pharmacology and experimental validation.
Topics: Animals; Cerebral Hemorrhage; Hematoma; Molecular Docking Simulation; Network Pharmacology; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Rats; Saponins; Stroke; Triterpenes | 2022 |
Astragaloside IV mitigates cerebral ischaemia-reperfusion injury via inhibition of P62/Keap1/Nrf2 pathway-mediated ferroptosis.
Topics: Animals; Brain Ischemia; Ferroptosis; Humans; Kelch-Like ECH-Associated Protein 1; Neuroblastoma; NF-E2-Related Factor 2; Oxygen; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Signal Transduction; Stroke | 2023 |
Astragaloside IV alleviates stroke-triggered early brain injury by modulating neuroinflammation and ferroptosis via the Nrf2/HO-1 signaling pathway.
Topics: Animals; Brain Injuries; Cytokines; Ferroptosis; Infarction; Neuroinflammatory Diseases; NF-E2-Related Factor 2; Rats; Rats, Sprague-Dawley; Signal Transduction; Stroke | 2023 |
Astragaloside IV improves neurobehavior and promotes hippocampal neurogenesis in MCAO rats though BDNF-TrkB signaling pathway.
Topics: Animals; Brain-Derived Neurotrophic Factor; Hippocampus; Infarction, Middle Cerebral Artery; Male; Neurogenesis; Neuroprotective Agents; Rats, Sprague-Dawley; Receptor, trkB; Saponins; Signal Transduction; Stroke; Triterpenes | 2020 |
Buyang Huanwu Decoction ameliorates ischemic stroke by modulating multiple targets with multiple components: In vitro evidences.
Topics: Animals; Apoptosis; Brain Ischemia; Drugs, Chinese Herbal; Glucosides; Isoflavones; Male; Mice; Mice, Inbred BALB C; Monoterpenes; PC12 Cells; Rats; Rats, Sprague-Dawley; RAW 264.7 Cells; Saponins; Stroke; Triterpenes | 2018 |
Astragaloside IV reversed the autophagy and oxidative stress induced by the intestinal microbiota of AIS in mice.
Topics: Animals; Antioxidants; Autophagy; Autophagy-Related Protein 12; Bacteria; Beclin-1; Brain; Disease Models, Animal; Fatty Acids; Feces; Gastrointestinal Microbiome; Genetic Vectors; Glutathione; Homocysteine; Ischemic Attack, Transient; Male; Malondialdehyde; Mice; Mice, Inbred C57BL; Microtubule-Associated Proteins; NADPH Oxidase 2; NADPH Oxidase 4; Oxidative Stress; Reactive Oxygen Species; Saponins; Stroke; Superoxide Dismutase; Triterpenes | 2018 |
Beneficial effect of astragalosides on stroke condition using PC12 cells under oxygen glucose deprivation and reperfusion.
Topics: Animals; Cell Death; Cell Line; Cell Survival; Glucose; Mitochondria; Neuroprotective Agents; Oxygen; p38 Mitogen-Activated Protein Kinases; PC12 Cells; Rats; Reperfusion Injury; Saponins; Stroke; Triterpenes | 2014 |